Form 4: Macrogenics Director David C. Stump Reports Stock Transactions
SEC Form 4 Filing
Director David C. Stump reports the vesting and disposal of 4,500 restricted stock units (RSUs) of Macrogenics Inc. on May 20, 2024.
Summary
- On May 20, 2024, David C. Stump, a director of Macrogenics Inc., reported a transaction involving restricted stock units (RSUs).
- The RSUs, representing a contingent right to receive one share of Macrogenics Common Stock each, vested on May 20, 2024.
- A total of 4,500 RSUs vested and were subsequently disposed of at a price of $0.
- Following the reported transaction, Mr. Stump directly owns 0 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in transactions involving the company's securities. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| May 31, 2023 | The restricted stock unit (RSU) grant was approved by the Board of Directors. |
| May 20, 2024 | Date of transaction: vesting and disposal of 4,500 RSUs. |
| May 21, 2024 | Issuer's 2024 Annual Meeting of Stockholders. |
| May 22, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.